Skip to main contentBack to Top

Welcome to the Dept. of Neuroscience & Regenerative Medicine at the Medical College of Georgia!

CA building side

The mission of the Department is to promote multidisciplinary research and teaching excellence in both biomedical and clinical sciences.

The Department was founded in 1993, formerly as the Institute of Molecular Medicine and Genetics. We seek to attract outstanding faculty and bright students by creating a welcoming, collegial and collaborative environment to foster success and creativity. Our faculty study a variety of fundamental questions ranging from neurodegenerative and neuropsychiatric disorders, brain injury, learning and memory, neuroprotection, development, inflammation and regenerative medicine, using a broad repertoire of experimental approaches. Our department is also the home to the Transgenic and Genome Editing Core supported by the Georgia Research Alliance.  

The Medical College of Georgia is the flagship medical school of the University System of Georgia, the state's only public medical school, and one of the top 5 largest medical schools in the United States. Founded nearly 200 years ago in 1828 as the nation's fifth public medical school, the third medical school in the Southeast and the thirteenth in the nation, the Medical College of Georgia has risen to its current role optimizing health care in Georgia and beyond through education, discovery, and service.


New Faculty Announcement
We are delighted to announce that Dr. Eric Vitriol will join our department as an associate professor this coming spring from the University of Florida. His research focuses on the regulation of actin during cell motility, neural development, and in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). Dr. Vitriol will bring his expertise in single-molecule super-resolution imaging to our department. He has received multiple awards, including a NINDS K99/R00 grant, an ALS Association grant and a NIGMS five-year renewable Maximizing Investigators’ Research Award (R35). He will work together with the ALS Center to develop a translational research program. Dr. Vitriol completed his postdoctoral training at Emory University and his Ph.D. in Cell and Developmental Biology at the University of North Carolina.


DNRM Seminars 2020-2021

Virtual Seminar @ 12:00pm

November 16, 2020
"A Bottom Up View of Thermogenic Fat"

Paul Cohen, MD, PhD
Albert Resnick, MD Asst. Professor
Head, Laboratory of Molecular Metabolism
The Rockefeller University

Virtual Seminar @ 12:00pm

November 23, 2020
"Modulation of Synaptic Plasticity in Neuronal Circuits by Microglia"

Brian MacVicar, PhD, FRSC, FCAHS
Djavad Mowafaghian Centre for Brain Health, Canada Research Chair in Neuroscience, Dept. of Psychiatry / Faculty of Medicine / University of British Columbia

Virtual Seminar @ 12:00pm

December 7, 2020
"The Role of GM1 Ganglioside in the Pathogenesis and Potential Treatment of Parkinson's Disease"

Jay Schneider, PhD
Professor, Dept. of Pathology, Anatomy and Cell Biology
Director, Parkinson's Diseases Research Unit
Thomas Jefferson University

Virtual Seminar @ 12:00pm

December 14, 2020

Li-Huei Tsai, PhD
Director, The Picower Institute for Learning and Memory at MIT
Picower Professor of Neuroscience
Department of Brain and Cognitive Sciences


Doctors in lab

Vitamin C’s effectiveness against COVID may hinge on vitamin’s natural transporter levels

High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.

Doctors in lab

Brain estrogen is key to brain protection when oxygen is low

When the brain isn’t getting enough oxygen, estrogen produced by neurons in both males and females hyperactivates another brain cell type called astrocytes to step up their usual support and protect brain function.

Man and woman in hospital setting

Patients with recently discovered antibodies have more severe myasthenia gravis

A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two newly discovered antibodies that also attack the point of communication between nerves and muscle.

Man in white lab coat

Mentoring through the years brings together two distinguished award winners

Two distinguished award winners at Augusta University understand the power of mentoring.




Contact Us

Neuroscience & Regenerative Medicine

Health Sciences Campus

Interdisciplinary Research Center


Ann Stephens

1120 15th St.,
CA-3008, Augusta, GA 30912

1462 Laney Walker Blvd.
Augusta, GA 30912